← Leaderboards
Asia Matthew
Univ Of Massachusetts Med Sch Worcester
$96,767
Attributed
$96,767
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $30.2K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$96,767 · 1
By mechanism
F31$96,767 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Eric H Baehrecke$18,715,067
- Heinrich Gottlinger$22,901,918
- Ameer Elaimy$154,909
- Andrei Korostelev$8,543,242
- Silvia Corvera$18,632,922
Others in their field
Top investigators on “Erbb2 Gene”
- Norman Wolmark · Nsabp Foundation, Inc.$43,988,954
- Charles M Perou · Univ Of North Carolina Chapel Hill$10,910,346
- Ellen M Velie · Michigan State University$10,395,017
- Leslie Bernstein · University Of Southern California$10,393,428
- Lewis A Chodosh · University Of Pennsylvania$10,338,684
- Carlos L Arteaga · Vanderbilt University$9,797,101
Research focus
Erbb2 GeneAutophagocytosisEpidermal Growth Factor Receptor1-Phosphatidylinositol 3-KinaseBreast Cancer TherapyBreast CarcinomaBreast Cancer CellCancer EtiologyCancer PrognosisCancer TherapyCause Of DeathCell DeathCellsCell SurvivalCessation Of LifeCancer DiagnosisClinical TrialsComplexCytokinesisDiagnosisDistant MetastasisEffective TherapyEndocytosisEstrogen Receptor Negative
Grant awards (4)
Impact of Beclin 1 Loss on Breast Cancer Progression$8,741
F31 · FY2019 · CA · contact PI
Impact of Beclin 1 Loss on Breast Cancer Progression$29,167
F31 · FY2018 · CA · contact PI
Impact of Beclin 1 Loss on Breast Cancer Progression$28,687
F31 · FY2017 · CA · contact PI
Impact of Beclin 1 Loss on Breast Cancer Progression$30,172
F31 · FY2016 · CA · contact PI